Abstract:Ursolic acid (UA) is a natural product which has been shown to possess a wide range of pharmacological activities, in particular those with anticancer activity. In this study, 13 novel ursolic acid derivatives were designed and synthesized in an attempt to further improve compound potency. The structures of the newly synthesized compounds were confirmed using mass spectrometry, infrared spectroscopy, and (1) H NMR. The ability of the UA derivatives to inhibit cell growth was assayed against both various tumor cell lines and a non-pathogenic cell line, HELF. Analysis of theoretical toxicity risks for all derivatives was performed using OSIRIS and indicated that the majority of compounds would present moderate to low risks. Pharmacological results indicated that the majority of the derivatives were more potent growth inhibitors than UA. In particular, 5b demonstrated IC50 values ranging from 4.09 ± 0.27 to 7.78 ± 0.43 μm against 12 different tumor cell lines. Flow cytometry analysis indicated that 5b induced G0/G1 arrest in three of these cell lines. These results were validated by structural docking studies, which confirmed that UA could bind to cyclins D1 (Cyc D1) and cyclin-dependent kinases (CDK6), the key regulators of G0/G1 transition in cell cycle, while the piperazine moiety of 5b could bind with glucokinase (GK), glucose transporter 1 (GLUT1), and ATPase, which are the main proteins involved in cancer cell metabolism. Acridine orange/ethidium bromide staining confirmed that 5b was capable of inducing apoptosis and decreasing cell viability in a dose-dependent manner.

Synthesis and biological evaluation of ursolic acid derivatives containing an aminoguanidine moiety

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Synthesis and Biological Evaluation of 1,3-Diaryl Pyrazole Derivatives As Potential Antibacterial and Anti-Inflammatory Agents.

Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents.

Synthesis and Biological Evaluation of Chalcone Derivatives Containing Aminoguanidine or Acylhydrazone Moieties

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

New ursolic acid derivatives bearing 1,2,3-triazole moieties: design, synthesis and anti-inflammatory activity in vitro and in vivo

Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.

Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives

Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents.

Synthesis and antitumor activity of novel quinoline derivatives of ursolic acid

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Synthesis and Biological Activity of 3-[(4-sulfamoylphenyl)hydroxy Methylene]-5-methyl-2-oxindole-1-carboxamides

Synthesis and Characterization of Ursolic Acid Derivatives, and the Study on the Antibacterial Activity

Synthesis and biological evaluation of novel aminoguanidine derivatives as potential antibacterial agents

Synthesis and biological evaluation of cyanoguanidine derivatives of loratadine.

Synthesis and Anti-angiogenesis Activities of Ursolic Acid Derivatives

The Synthesis of Ursolic Acid Derivatives with Cytotoxic Activity and the Investigation of Their Preliminary Mechanism of Action.

Synthesis And Anti-Inflammatory Activity Of 3-Acetyl-2-[(Un)Substituted Phenyl]-2,3-Dihydro-1,3,4-Oxadiazol-5-Methyl 3-O-Acetylursolate

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Synthesis and Antimicrobial Evaluation of Aminoguanidine and 3-Amino- 1,2,4-Triazole Derivatives As Potential Antibacterial Agents